Clinical Trials List
2022-07-01 - 2027-02-26
Phase II
Not yet recruiting4
Recruiting4
ICD-10B15.0
Hepatitis A with hepatic coma
ICD-9070.0
Viral hepatitis A with hepatic coma
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Ming-Lung Yu Digestive System Department
- 梁博程 Digestive System Department
- Ming-Lun Yeh Digestive System Department
- 黃駿逸 Digestive System Department
- Chia-Yen Dai Digestive System Department
- Jee-Fu Huang Digestive System Department
- Chung-Feng Huang Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 許銘澤 Digestive System Department
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Hsueh-Chou Lai Digestive System Department
- Hung-Wei Wang Digestive System Department
- Wei-Fan Hsu Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chau-Ting Yeh Digestive System Department
- Yi-Cheng Chen Digestive System Department
- Chen-Chun Lin Digestive System Department
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 吳毅晉 Division of General Internal Medicine
- Hsin-Yu Kuo Division of General Internal Medicine
- 邱彥程 Division of General Internal Medicine
- Chiu Hung Chiu Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Jia-Horng Kao Division of General Internal Medicine
- 曾岱宗 Division of General Internal Medicine
- 蘇東弘 Division of General Internal Medicine
- PEI-JER CHEN Division of General Internal Medicine
- 楊宏志 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
70 participants
-
Global
120 participants